A Study of Lung Cancer Risk

Purpose

The researchers are doing this study to learn more about factors that may increase the risk of lung cancer in people who have never smoked. This information may help predict which people who have never smoked may be more likely to get lung cancer.

Condition

  • Lung Cancer

Eligibility

Eligible Ages
Between 40 Years and 74 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Criteria

Criteria:

- Female at birth

- Age 40-74 years

- No smoking history

- Participants must be never-smokers, defined as having smoked <100 cigarettes in
their lifetime

- Documentation of disease - case patients

o Case patients must have pathologically confirmed primary lung adenocarcinoma. New
and prevalent cases will be eligible. Case patients with a history of prior non-lung
cancer will be eligible for the study unless actively being diagnosed or treated for
another form of cancer at the time of enrollment.

- Criteria for control participants

- Control participants must have no personal history of lung cancer, symptoms
suspicious for lung cancer, or suspicious pulmonary nodules. Participants
recruited as controls and found on imaging to have lesions suspicious for lung
cancer will be excluded from analysis and followed prospectively. Data
regarding these participants will be reported in a sensitivity analysis.
Additional control participants will be recruited to ensure balanced age- and
race-matched enrollment by frequency matching. Control participants with a
history of prior non-lung cancer will be eligible for the study unless actively
being diagnosed or treated for another form of cancer at the time of
enrollment.

Study Design

Phase
Study Type
Observational
Observational Model
Case-Control
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Case patients Must have pathologically confirmed primary lung adenocarcinoma.
  • Other: Questionnaire
    The study questionnaire will be administered at a regular treatment visit for case patients and at a study-specific visit for control participants. At the same visit, 1 vial of blood will be collected for genomic analysis for research purposes from both case patients and control participants. Collection of demographic information and exposure data.
Control participants Must have no personal history of lung cancer, symptoms suspicious for lung cancer, or suspicious pulmonary nodules.
  • Other: Questionnaire
    The study questionnaire will be administered at a regular treatment visit for case patients and at a study-specific visit for control participants. At the same visit, 1 vial of blood will be collected for genomic analysis for research purposes from both case patients and control participants. Collection of demographic information and exposure data.

Recruiting Locations

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey 07920
Contact:
Alexis Chidi, MD, PhD
212-639-3104

Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey 07748
Contact:
Alexis Chidi, MD, PhD
212-639-3104

Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey 07645
Contact:
Alexis Chidi, MD, PhD
212-639-3104

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack, New York 11725
Contact:
Alexis Chidi, MD, PhD
212-639-3104

Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York 10604
Contact:
Alexis Chidi, MD, PhD
212-639-3104

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
Contact:
Alexis Chidi, MD, PhD
212-639-3104

Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York 11553
Contact:
Alexis Chidi, MD, PhD
212-639-3104

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Alexis Chidi, MD, PhD
212-639-3104
chidia1@mskcc.org